← Oncology Approval Tracker

FDA DECISION ·

Methotrexate Injection (Accord)

methotrexate · Accord Healthcare

FDA approvalNew or expanded indicationNon-Hodgkin lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

The methotrexate injection label expanded its non-Hodgkin lymphoma indication to include pediatric patients. The supplement also revised dosing for ALL and NHL.

LAMPGEN ANALYSIS

Why it matters

The revision consolidates Burkitt lymphoma within NHL and extends the labeled lymphoma population to children.

What research teams should watch

Update pediatric protocol references and verify indication-specific dosing, route and rescue requirements.

PRIMARY RECORDS

Sources